Fatima, I.; Ahmed, M.; Mohamed, W.T.; Jahagirdar, V.; Kennedy, K.F.; Likhitsup, A.
Outcomes and Predictors of 30-Day Readmission in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization between 2016 and 2018. Gastroenterol. Insights 2024, 15, 87-97.
https://doi.org/10.3390/gastroent15010006
AMA Style
Fatima I, Ahmed M, Mohamed WT, Jahagirdar V, Kennedy KF, Likhitsup A.
Outcomes and Predictors of 30-Day Readmission in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization between 2016 and 2018. Gastroenterology Insights. 2024; 15(1):87-97.
https://doi.org/10.3390/gastroent15010006
Chicago/Turabian Style
Fatima, Ifrah, Mohamed Ahmed, Wael T. Mohamed, Vinay Jahagirdar, Kevin F. Kennedy, and Alisa Likhitsup.
2024. "Outcomes and Predictors of 30-Day Readmission in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization between 2016 and 2018" Gastroenterology Insights 15, no. 1: 87-97.
https://doi.org/10.3390/gastroent15010006
APA Style
Fatima, I., Ahmed, M., Mohamed, W. T., Jahagirdar, V., Kennedy, K. F., & Likhitsup, A.
(2024). Outcomes and Predictors of 30-Day Readmission in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization between 2016 and 2018. Gastroenterology Insights, 15(1), 87-97.
https://doi.org/10.3390/gastroent15010006
